Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Rexahn Pharmaceuticals, Inc. (RNN) Starts Presentation at 2nd Annual Marcum MicroCap Conference

Posted on May 30, 2013 by MissionIR

Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and commercialization of first-in-class therapeutics for the treatment of cancer and other unmet medical needs. The company currently has three clinical stage oncology candidates, Archexin®, RX-3117, and RX-5902, as well as a pipeline of preclinical compounds to treat multiple types of cancer. RNN has also developed proprietary drug discovery platform technologies in the areas of nano-medicines, 3D-GOLD, and TIMES. For more information visit the company’s Web site at www.rexahn.com

Let us hear your thoughts below:

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *